glp-1 information The revolution: What UAB researchers are discovering about how these drugs work The GLP-1 revolution: What UAB

Promotes Regularity*

Based on this review, evidence from head-to-head and insulin-comparator trials demonstrates that dual GIP/GLP-1 co-agonism consistently overcomes metabolic plateaus that result from single-pathway therapy, producing superior glycated hemoglobin reduction, bariatric-level weight loss (up to 25.3%), and robust macrovascular and heart failure protection, including a 38% reduction in composite cardiovascular risk among patients with heart failure with preserved ejection fraction (HFpEF)

Helps regulate appetite and feelings of fullness

Hops extract stimulates satiety for faster appetite control and helps decrease insulin resistance and balance blood glucose levels.*

KIDNEY FUNCTION